Compare Verizon Communications Inc (VZ) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Verizon Communications Inc vs GeneDx Holdings Corp — how do they compare? Verizon Communications Inc trades at $49.79 (market cap $209.44B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: Verizon Communications Inc is far larger — about 81.8× GeneDx Holdings Corp's market cap, and Verizon Communications Inc pays a 5.61% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| VZ | WGS | |
|---|---|---|
Market Cap | $209.44B | $2.56B |
Volume | 22,584,735 | — |
Sector | Media | Technology |
52-Week High | $51.38 | $167.51 |
52-Week Low | $38.40 | $34.51 |
Enterprise Value | $396.15B | $2.60B |
Dividend Yield | 5.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Verizon (VZ) trades at $50.41, up 0.54% today, with a bullish technical signal and strong fundamental metrics including a 15.63% ROE and 11.64% net margin. Recent earnings beats and a 5%+ dividend yield support investor confidence, while the stock trades below the consensus price target of $49.69. The company's fiber expansion deal with Corning and focus on broadband growth provide positive momentum.
Outlook remains positive with cost discipline and shareholder returns driving value, though high debt levels and competitive pressures pose risks. The stock offers income appeal with growth potential from AI infrastructure investments, but requires monitoring of execution on turnaround initiatives.
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
